Christopher Wilks - Sonic Healthcare Finance Director, Executive Director
SKHCF Stock | USD 18.87 0.20 1.07% |
Director
Mr. Christopher David Wilks is a Chief Financial Officer, Finance Director, Executive Director of Sonic HealthCare Limited. Mr Wilks became Finance Director and Chief Financial Officer of Sonic Healthcare in 1993. He has a background in chartered accounting and investment banking and was previously a partner in a private investment bank. Mr Wilks has held directorships in a number of public companies and is currently a nonexecutive Director of Silex Systems Limited, a listed company divested by Sonic in 1996. since 2014.
Age | 59 |
Tenure | 10 years |
Phone | 61 2 9855 5444 |
Web | https://www.sonichealthcare.com |
Sonic Healthcare Management Efficiency
The company has return on total asset (ROA) of 0.1111 % which means that it generated a profit of $0.1111 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2175 %, meaning that it generated $0.2175 on every $100 dollars invested by stockholders. Sonic Healthcare's management efficiency ratios could be used to measure how well Sonic Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
A Sanders | Danaher | 58 | |
Lars Sorensen | Thermo Fisher Scientific | 67 | |
Todd Sisitsky | IQVIA Holdings | 49 | |
Scott Sperling | Thermo Fisher Scientific | 63 | |
Debora Spar | Thermo Fisher Scientific | 56 | |
Elias Zerhouni | Danaher | 69 | |
Alan Spoon | Danaher | 69 | |
Nelson Chai | Thermo Fisher Scientific | 55 | |
Sophie Vandebroek | IDEXX Laboratories | 56 | |
WahHui Chu | Mettler Toledo International | 69 | |
John Connaughton | IQVIA Holdings | 54 | |
Mala Anand | Agilent Technologies | 53 | |
Bruce Claflin | IDEXX Laboratories | 66 | |
Raymond Stevens | Danaher | 57 | |
Barry Johnson | IDEXX Laboratories | 71 | |
Jonathan Coslet | IQVIA Holdings | 53 | |
Thomas Salice | Mettler Toledo International | 61 | |
Elaine Ullian | Thermo Fisher Scientific | 70 | |
Martiny Harris | Thermo Fisher Scientific | 59 | |
Kevin Brown | Kroger Company | 57 | |
Walter Lohr | Danaher | 77 |
Management Performance
Return On Equity | 0.22 | |||
Return On Asset | 0.11 |
Sonic Healthcare Leadership Team
Elected by the shareholders, the Sonic Healthcare's board of directors comprises two types of representatives: Sonic Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sonic. The board's role is to monitor Sonic Healthcare's management team and ensure that shareholders' interests are well served. Sonic Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sonic Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Julian Adler, Chief Imaging | ||
Mrs Schottdorf, Chief Group | ||
Neville Mitchell, Non-Executive Independent Director | ||
BEc CA, Deputy Sec | ||
Louis Panaccio, Non-Executive Independent Director | ||
Colin Goldschmidt, CEO, Managing Director, Investor Relations Contact Officer, Executive Director | ||
Peter Savage, Chief Officer | ||
Elizabeth Wilson, Independent Non-Executive Director | ||
Philip Dubois, Executive Director | ||
Kathryn Spargo, Non-Executive Independent Director | ||
Stephen Fairy, Global Officer | ||
Christopher Wilks, Finance Director, Executive Director | ||
FAICD FRCPA, MD CEO | ||
BCom FACID, CFO Director | ||
David Byrne, Chief Laboratory | ||
Prashan Kulasekera, Assistant Sec | ||
Mark Compton, Non-Executive Independent Director | ||
Paul Alexander, Company Secretary |
Sonic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sonic Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.22 | |||
Return On Asset | 0.11 | |||
Profit Margin | 0.16 % | |||
Operating Margin | 0.23 % | |||
Current Valuation | 11.17 B | |||
Shares Outstanding | 480.98 M | |||
Shares Owned By Insiders | 5.09 % | |||
Shares Owned By Institutions | 38.62 % | |||
Price To Earning | 13.88 X | |||
Price To Book | 1.98 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sonic Healthcare in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sonic Healthcare's short interest history, or implied volatility extrapolated from Sonic Healthcare options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sonic Healthcare Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Sonic Healthcare information on this page should be used as a complementary analysis to other Sonic Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Sonic Pink Sheet analysis
When running Sonic Healthcare's price analysis, check to measure Sonic Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sonic Healthcare is operating at the current time. Most of Sonic Healthcare's value examination focuses on studying past and present price action to predict the probability of Sonic Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sonic Healthcare's price. Additionally, you may evaluate how the addition of Sonic Healthcare to your portfolios can decrease your overall portfolio volatility.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |